Stock & Company Details
Beam Therapeutics Inc $BEAM
Price:
N/A
N/A
103M
$2.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
-30.20
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BEAM technical indicators
Latest Beam Therapeutics Inc (BEAM) indicator readings as of 2026-10-09.
BEAM's 14-day RSI is 51.5, in neutral territory. At $25.70 it is trading 9.6% below its 200-day moving average of $28.44, and below its 50-day average of $26.52. Price sits near the upper Bollinger Band ($23.23 to $26.04). ADX reads 13.7, indicating a range-bound market rather than a trend.
Overview
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Finance Bot
Ask your questions
Start by typing a question below.
